Designing multi-target drugs for the treatment of major depressive disorder

AK Halder, S Mitra, MNDS Cordeiro - Expert Opinion on Drug …, 2023 - Taylor & Francis
Introduction Major depressive disorders (MDD) pose major health burdens globally.
Currently available medications have their limitations due to serious adverse effects, long …

Investigational melatonin receptor agonists

R Hardeland - Expert opinion on investigational drugs, 2010 - Taylor & Francis
Importance of the field: Melatonin is a major chronobiological regulator involved in circadian
phasing, sleep, and numerous other functions including cyto-/neuroprotection, immune …

Design and synthesis of 3-phenyl tetrahydronaphthalenic derivatives as new selective MT2 melatoninergic ligands

S Yous, S Durieux-Poissonnier, E Lipka-Belloli… - Bioorganic & medicinal …, 2003 - Elsevier
Tetrahydronaphthalenic analogues of melatonin have been synthesized and evaluated as
melatonin receptor ligands. Introduction of a phenyl substituent in the 3-position of the …

Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt1 and MT2 receptors

C Pégurier, S Curtet, JP Nicolas, JA Boutin… - Bioorganic & medicinal …, 2000 - Elsevier
Focused small libraries of melatonin receptor ligands from arylalkylamine derivatives were
synthesised by combinatorial chemistry using the mix and split method in the solid phase. A …

Potentiating the benefits of melatonin through chemical functionalization: possible impact on multifactorial neurodegenerative disorders

A Galano, EG Guzmán-López, RJ Reiter - International journal of …, 2021 - mdpi.com
Although melatonin is an astonishing molecule, it is possible that chemistry will help in the
discovery of new compounds derived from it that may exceed our expectations regarding …

Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors

C Marot, P Chavatte, L Morin-Allory… - Journal of medicinal …, 1998 - ACS Publications
Conformational analysis was used to characterize the agonist pharmacophore for melatonin
sheep brain receptor recognition and activation. The molecular geometry shared by all …

Synthesis and Functional Characterization of Substituted Isoquinolinones as MT2-Selective Melatoninergic Ligands

Y Hu, KH Chan, X He, MKC Ho, YH Wong - Plos one, 2014 - journals.plos.org
A series of substituted isoquinolinones were synthesized and their binding affinities and
functional activities towards human melatonin MT1 and MT2 receptors were evaluated …

Development of substituted N-[3-(3-methoxylphenyl) propyl] amides as MT2-selective melatonin agonists: Improving metabolic stability

Y Hu, J Zhu, KH Chan, YH Wong - Bioorganic & medicinal chemistry, 2013 - Elsevier
A series of novel and selective N-[3-(6-benzyloxy-3-methoxyphenyl) propyl] amides has
recently been shown to possess sub-nanomolar range binding affinity to the type 2 …

Synthetic melatoninergic ligands: achievements and prospects

NV Kostiuk, MB Belyakova… - International …, 2014 - Wiley Online Library
Pineal hormone melatonin is widely used in the treatment of disorders of circadian rhythms.
The presence of melatonin receptors in various animal tissues motivates the use of this …

N‐(Anilinoethyl)amides: Design and Synthesis of Metabolically Stable, Selective Melatonin Receptor Ligands

S Rivara, F Vacondio, A Fioni, C Silva… - ChemMedChem …, 2009 - Wiley Online Library
The class of N‐(anilinoethyl) amides includes melatonin receptor ligands with varied
subtype selectivity and intrinsic activity. One of these ligands, the MT2‐selective partial …